FDA Adverse Event Injury Summary report: N

HEARTMATE 3 LVAS IMPLANT KIT

MDR report key: 14167790 · Received April 21, 2022

Report

Report Number
2916596-2022-10476
Event Type
Injury
Date Received
April 21, 2022
Date of Event
April 10, 2022
Report Date
April 21, 2022
Manufacturer
THORATEC CORPORATION
Product Code
DSQ
UDI-DI
00813024013297
PMA / PMN Number
P160054
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION CONCLUSION: THE PUMP REMAINS IN USE SUPPORTING THE PATIENT. A CORRELATION BETWEEN THE DEVICE AND THE REPORT OF GASTROINTESTINAL (GI) BLEEDING COULD NOT BE CONCLUSIVELY DETERMINED. BLEEDING IS LISTED IN THE INSTRUCTIONS FOR USE AS A POTENTIAL ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. GI BLEEDING HAS BEEN PREVIOUSLY INVESTIGATED AND WILL CONTINUE TO BE MONITORED THROUGH QUALITY DATA REVIEWS, WHICH ARE CONDUCTED ON PRODUCTION AND POST PRODUCT SIGNALS TO EVALUATE IF PRODUCTS ARE CONFORMING TO PRODUCT REQUIREMENTS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT EXPERIENCED MELENA ON (B)(6) 2022; WARFARIN WAS WITHHELD UNTIL (B)(6) 2022. THE PATIENT VISITED THE EMERGENCY ROOM ON (B)(6) 2022 DUE TO POOR ORAL INTAKE AND DECREASED MENTAL STATUS. THE PATIENT WAS DIAGNOSED WITH HYPOVOLEMIC SHOCK. AN UPPER GASTROINTESTINAL ENDOSCOPY (EGD) AND SIGMOIDOSCOPY (SFS) WERE PERFORMED TO RULE OUT A GASTROINTESTINAL (GI) BLEED, AND BLOOD AND PLASMA TRANSFUSIONS WERE PERFORMED. A SOURCE OF THE PATIENT'S BLEEDING COULD NOT BE IDENTIFIED. THE PATIENT'S CONDITION WAS IMPROVING FOLLOWING THE TRANSFUSIONS AND THE EVENT WAS CONSIDERED RESOLVED ON (B)(6) 2022.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1772069 HEARTMATE 3 LVAS IMPLANT KIT VENTRICULAR (ASSISST) BYPASS DSQ THORATEC CORPORATION 106524US 8011941 00813024013297

Patients

Seq Age Sex Outcome Treatment
1 76 YR Female Required Intervention| H